Brokerages forecast that Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) will post sales of $943.16 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Option Care Health’s earnings, with the lowest sales estimate coming in at $933.40 million and the highest estimate coming in at $956.73 million. Option Care Health posted sales of $860.27 million in the same quarter last year, which suggests a positive year over year growth rate of 9.6%. The business is expected to report its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Option Care Health will report full year sales of $3.85 billion for the current financial year, with estimates ranging from $3.82 billion to $3.90 billion. For the next year, analysts expect that the business will post sales of $4.18 billion, with estimates ranging from $4.10 billion to $4.27 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Option Care Health.
Option Care Health (NASDAQ:OPCH – Get Rating) last posted its earnings results on Thursday, April 28th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The firm had revenue of $915.78 million for the quarter, compared to the consensus estimate of $839.45 million. Option Care Health had a net margin of 4.81% and a return on equity of 12.53%. The business’s quarterly revenue was up 20.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.02) earnings per share.
OPCH has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of Option Care Health from $32.00 to $39.00 in a research report on Friday, April 29th. Zacks Investment Research downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Tuesday, May 3rd. Barrington Research upped their price target on shares of Option Care Health from $31.00 to $33.00 in a report on Friday, April 29th. Finally, TheStreet cut shares of Option Care Health from a “b” rating to a “c+” rating in a report on Thursday, April 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $31.17.
Option Care Health stock opened at $26.47 on Thursday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.59 and a quick ratio of 1.16. The firm has a market capitalization of $4.77 billion, a P/E ratio of 27.57, a price-to-earnings-growth ratio of 1.35 and a beta of 1.27. Option Care Health has a one year low of $16.17 and a one year high of $30.70. The stock’s fifty day simple moving average is $27.78.
In related news, COO Harriet Booker sold 6,000 shares of the stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $28.81, for a total value of $172,860.00. Following the completion of the sale, the chief operating officer now owns 81,511 shares in the company, valued at $2,348,331.91. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In the last quarter, insiders sold 18,000 shares of company stock valued at $492,660. 0.22% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. American Century Companies Inc. bought a new position in Option Care Health during the first quarter worth about $907,000. First Eagle Investment Management LLC lifted its stake in Option Care Health by 192.7% during the first quarter. First Eagle Investment Management LLC now owns 26,626 shares of the company’s stock worth $760,000 after purchasing an additional 17,530 shares during the period. Crossmark Global Holdings Inc. lifted its stake in Option Care Health by 4.4% during the first quarter. Crossmark Global Holdings Inc. now owns 12,470 shares of the company’s stock worth $356,000 after purchasing an additional 530 shares during the period. Handelsbanken Fonder AB lifted its stake in Option Care Health by 47.7% during the first quarter. Handelsbanken Fonder AB now owns 333,100 shares of the company’s stock worth $9,513,000 after purchasing an additional 107,600 shares during the period. Finally, State of Tennessee Treasury Department increased its holdings in shares of Option Care Health by 50.0% during the first quarter. State of Tennessee Treasury Department now owns 180,000 shares of the company’s stock worth $5,141,000 after buying an additional 60,000 shares in the last quarter. Hedge funds and other institutional investors own 98.23% of the company’s stock.
About Option Care Health (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Want More Great Investing Ideas?
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.